Compound class
Growth hormone peptides
Growth hormone and related compounds.
Somatropin is recombinant human growth hormone,1 tesamorelin is a synthetic analogue of growth hormone-releasing factor,2 and ipamorelin is described as a growth hormone secretagogue.3 MK-677 (ibutamoren) is a non-peptide small molecule that FDA documents say is not a component of an FDA-approved drug,4 and a trial in older adults gave it by mouth once daily.5 FDA's 2026 briefing weighs against adding it to the 503A bulks list for compounding and describes a trial in older people recovering from hip fracture that was terminated early due to a safety signal of congestive heart failure.4 The WADA 2026 list names several of these compounds as prohibited at all times.6
Growth hormone peptides 20
-
Tesamorelin
GHRH analog
- Half-life
- Not stated
- Given
- Once daily
- Form or status
- Has a US label
-
CJC-1295 + Ipamorelin
Blend
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
Human growth hormone
Growth hormone
- Half-life
- 2.3 hours
- Given
- Not stated
- Form or status
- Has a US label
-
Ipamorelin
GHRP
- Half-life
- 2 hours after 15-minute IV infusions
- Given
- Twice daily IV infusion after surgery (one trial)
- Form or status
- No product label among its sources
-
CJC-1295 (no DAC)
GHRH analog
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
CJC-1295 with DAC
GHRH analog
- Half-life
- 8 to 10 days
- Given
- Not stated
- Form or status
- No product label among its sources
-
Follistatin-315
Binding protein
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
GHRP-2
GHRP
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
GHRP-6
GHRP
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
Hexarelin
GHRP
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
hGH Fragment 176-191
GH fragment
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
IGF-1 DES
IGF-1 analog
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
IGF-1 LR3
Growth factor
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- Not stated
-
Kisspeptin-10
Hypothalamic peptide
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
MGF (Mechano Growth Factor)
Growth factor peptide
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
MK-677
GH secretagogue (Oral)
- Half-life
- Not stated
- Given
- Once daily by mouth in studies
- Form or status
- No product label among its sources
-
PEG-MGF (Pegylated Mechano Growth Factor)
IGF-1 splice variant
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
Sermorelin
GHRH analog
- Half-life
- 6 to 7 minutes (IV, Irish Geref label)
- Given
- One IV injection for a diagnostic test (Irish label)
- Form or status
- US approvals withdrawn at the holder's request, not for safety or effectiveness (FDA)
-
Sermorelin + Ipamorelin
Blend
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
Tesamorelin + Ipamorelin
Blend
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- Not stated
Metabolic 1
Half-lives side by side
The figure each source gives, on one scale. Bars are ranges.
- Sermorelin6 to 7 min, IV
- Ipamorelin2 h, IV
- Human growth hormone2.3 h
- CJC-1295 with DAC8 to 10 days
Log scale, 1 minute to about 3 weeks. Each figure and its source are in the list above. Minutes, days and weeks are turned into hours (1 day is 24 hours) only to place them on the scale. These are the sources' figures; the half-life the app uses to draw levels can differ.
Where some figures in the list come from
- Ipamorelin: FDA says a published study identified serious adverse events including death when ipamorelin was given intravenously for improving gastric motility.7
Guides 19
- AOD-9604 dosage: mixing and units per doseTrial doses of AOD-9604 by mouth and vein, what FDA and TGA records show, vial and water arithmetic for syringe units, and the storage figures reported.
- CJC-1295 and ipamorelin dosage: blend logs, separate trialsNo label gives a dose for this blend. Logged vial setups, a worked syringe mark, and separate trials of CJC-1295 with DAC and of intravenous ipamorelin.
- GHRP-2 dosage: the Japanese diagnostic label and trialsThe one GHRP-2 label found, a Japanese diagnostic one, gives adults 100 mcg intravenously once. Trial doses by route, mixing, syringe units, storage.
- GHRP-6 dosage: mixing and syringe unitsDoses and schedules from human GHRP-6 studies, what is not known, and syringe arithmetic for a 5 mg vial on a U-100 syringe, with sources.
- Hexarelin dosage: mixing and syringe unitsHexarelin doses and schedules used in human trials, and the arithmetic that turns a dose into mL and U-100 syringe units for a powder vial.
- HGH dosage in IU: a 10 IU vial and units per doseWhat labels and trials give for somatropin doses in IU and mg, how a 10 IU vial maps to syringe units, and how long a mixed vial keeps.
- HGH fragment 176-191 dosage: mixing and unitsDailyMed lists no label for hGH fragment 176-191. AOD9604 trials gave oral and intravenous doses. Vial maths and syringe marks for 2 mg and 5 mg vials.
- How many units of CJC-1295 DAC: trial doses and mathsNo label sets a CJC-1295 with DAC dose. Trial doses in µg/kg, the forum pattern in mg per week, and the syringe arithmetic for a 2 mg vial.
- How much CJC-1295 per day: no DAC, forum reports and logsForum-reported schedules for CJC-1295 without DAC, syringe arithmetic for logged 5 mg and 10 mg vials, and what the trials, all of the DAC form, cover.
- How much ipamorelin per day: mixing and unitsIpamorelin has no label dose. Trial doses and schedules, the doses logged in Milligram, and how a dose maps to units on a U-100 syringe.
- IGF-1 DES dosage: mixing and syringe unitsSearches found no IGF-1 DES label or human trial dose. What rat studies gave, and how it differs from mecasermin (Increlex), a full-length IGF-1 product.
- IGF-1 LR3 dosage: mixing a 1 mg vial and unitsNo label or human trial gives an IGF-1 LR3 dose. A review reports forum dosing; here is the arithmetic for a 1 mg vial on a U-100 syringe.
- Ipamorelin and sermorelin stack: evidence for each peptideNo label or trial doses the pair. Evidence for each peptide alone, and a syringe example for a logged 10 mg vial of ipamorelin only.
- Ipamorelin and tesamorelin dosage: each drug's evidenceEGRIFTA SV's label gives 1.4 mg once daily and WR's 1.28 mg, not substitutable. No label or trial doses the blend; the syringe example is tesamorelin only.
- MGF dosage: mixing and syringe unitsNo label or human trial found gives an MGF dose. The online PEG-MGF regimens a 2026 review tabulates, and why no vial mix or syringe mark can be sourced.
- MK-677 dosage per day: what studies usedWhat the FDA briefing and human trials give for MK-677 per day: 2 to 50 mg by mouth, 0.2 to 0.8 mg/kg in children, plus strengths and storage.
- PEG-MGF dosage: mixing and syringe unitsNo label or human trial dose for PEG-MGF turned up in searches. Forum-sourced figures from a 2026 review, plus the syringe arithmetic for a 2 mg vial.
- Sermorelin dosage: historical vials and study dosesFDA lists discontinued Geref vials of 0.5 mg and 1.0 mg. A secondary text conflicts on the dose unit, so syringe figures here are arithmetic only.
- Tesamorelin dosage: labelled products and logged 10 mg vialsTesamorelin label doses and storage for the EGRIFTA SV and WR products, trial doses, and syringe arithmetic for the 10 mg vials logged in Milligram.
Calculators 15
- AOD-9604 reconstitution calculator and chartUnits on a U-100 syringe for AOD-9604: enter the powder in your vial, the water you add and your dose, in mg or mcg, to see the mark.
- CJC-1295 and ipamorelin dosage calculatorUnits on a U-100 syringe for CJC-1295 + ipamorelin: enter your vial, water and dose, or print the chart for 10 and 20 mg vials.
- CJC-1295 DAC dosage calculator: vials, water and unitsUnits on a U-100 syringe for CJC-1295 with DAC: enter the powder in your vial, the water you add and your dose, in mg or mcg, to see the mark.
- CJC-1295 dosage calculator: no DAC, 10 mg vialUnits on a U-100 syringe for CJC-1295 (no DAC): enter your vial, water and dose, or print the chart for 5 and 10 mg vials.
- GHRP-2 dosage calculator: vials, water and unitsUnits on a U-100 syringe for GHRP-2: enter the powder in your vial, the water you add and your dose, in mg or mcg, to see the mark.
- GHRP-6 dosage calculator: vials, water and unitsUnits on a U-100 syringe for GHRP-6: enter the powder in your vial, the water you add and your dose, in mg or mcg, to see the mark.
- Hexarelin dosage calculator: vials, water and unitsUnits on a U-100 syringe for hexarelin: enter the powder in your vial, the water you add and your dose, in mg or mcg, to see the mark.
- HGH calculator: IU and syringe units by vialIU and syringe units for human growth hormone (somatropin), kept apart: enter your vial, water and dose, or print the chart for 18, 36 and 72 IU vials.
- IGF-1 LR3 dosage calculator: 1 mg vialUnits on a U-100 syringe for IGF-1 LR3: enter the powder in your vial, the water you add and your dose, in mg or mcg, to see the mark.
- Ipamorelin dosage calculator: 5 and 10 mg vialsUnits on a U-100 syringe for ipamorelin: enter your vial, water and dose, or print the chart for 5 and 10 mg vials.
- Kisspeptin dosage calculator and reconstitutionUnits on a U-100 syringe for kisspeptin-10: enter the powder in your vial, the water you add and your dose, in mg or mcg, to see the mark.
- MGF calculator: vials, water and unitsUnits on a U-100 syringe for MGF (Mechano Growth Factor): enter the powder in your vial, the water you add and your dose, in mg or mcg, to see the mark.
- Sermorelin dosage calculator: 5 and 10 mg vialsUnits on a U-100 syringe for sermorelin: enter the powder in your vial, the water you add and your dose, in mg or mcg, to see the mark.
- Tesamorelin dosage calculator: 10 mg vial chartUnits on a U-100 syringe for tesamorelin: enter your vial, water and dose, or print the chart for 5, 10 and 20 mg vials.
- Tesamorelin ipamorelin calculator: vials, water and unitsUnits on a U-100 syringe for tesamorelin + ipamorelin: enter the powder in your vial, the water you add and your dose, in mg or mcg, to see the mark.
Compare 4
- CJC-1295 with DAC vs no DACCJC-1295 with and without DAC compared on what each form is, how each was given, half-life, studied doses and status, with each figure sourced.
- Ipamorelin vs sermorelinIpamorelin and sermorelin compared on what each peptide is, how each comes or was given, half-life, studied doses and status, with sources.
- Ipamorelin vs tesamorelinIpamorelin and tesamorelin compared on what each peptide is, how each was given, half-life, studied doses and status, with each figure sourced.
- Sermorelin vs tesamorelinSermorelin and tesamorelin compared on what each peptide is, how each comes, label half-life, labelled doses and status, with each figure sourced.
Logged in Milligram
Share of people who logged a dose in Milligram in the 90 days to 15 November 2026 who logged each compound.
Tesamorelin, how often
CJC-1295 + Ipamorelin, how often
Human growth hormone, how often
Ipamorelin, how often
How often: among people with three or more logged doses, by the average gap between their doses.
Aggregated and anonymous, shares of people only. Each compound not listed: too few people logged it to show a share. It describes what people set up in the app, not advice on what to take.
References 14
- Pfizer Laboratories Div Pfizer Inc. GENOTROPIN (somatropin) for injection, prescribing information (DailyMed, effective 4 August 2026). 2026. DailyMed label
- Theratechnologies Inc. EGRIFTA WR (tesamorelin) for injection, prescribing information. 2026. DailyMed label
- Raun K, Hansen BS, Johansen NL, Thøgersen H, Madsen K, Ankersen M, Andersen PH. Ipamorelin, the first selective growth hormone secretagogue. 1998. PMID 9849822
- US Food and Drug Administration. FDA Briefing Document, Pharmacy Compounding Advisory Committee (PCAC) Meeting, October 29, 2024: Ibutamoren Mesylate. 2024. fda.gov
- Chapman IM, et al. Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects. J Clin Endocrinol Metab 1996. PMID 8954023
- World Anti-Doping Agency. World Anti-Doping Code International Standard Prohibited List 2026. 2026. wada-ama.org
- US Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks (content current as of 22 April 2026). FDA category 2 list
- Ferring Pharmaceuticals Inc. Zomacton (somatropin) kit, prescribing information. DailyMed, label effective 20 April 2026. DailyMed label (Zomacton)
- Novo Nordisk. Norditropin (somatropin) injection, solution, prescribing information. DailyMed, label effective 7 July 2025. DailyMed label (Norditropin)
- Gobburu JV, et al. Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers. Pharm Res 1999. PMID 10496658
- Beck DE, Sweeney WB, McCarter MD; Ipamorelin 201 Study Group. Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients. Int J Colorectal Dis 2014. Springer, DOI 10.1007/s00384-014-2030-8
- Sackmann-Sala L, Ding J, Frohman LA, Kopchick JJ. Activation of the GH/IGF-1 axis by CJC-1295, a long acting GHRH analog, results in serum protein profile changes in normal adult subjects. Growth Horm IGF Res 2009;19:471-7. PMC2787983
- Irish Medicines Board. Summary of Product Characteristics: Geref 50 (sermorelin acetate), printed 13 July 2006. HPRA Geref 50 SmPC
- Food and Drug Administration. Determination that GEREF (sermorelin acetate) injection was not withdrawn from sale for reasons of safety or effectiveness. Federal Register 2013;78(42):14095-14096. Federal Register 2013-04827
Each figure is as the compound's own sources give it, numbered under References. Where they give none, the list says not stated. The half-life the app draws levels with can differ. Reviewed 17 November 2026.